Entrada Therapeutics (TRDA) Q2 2026 Earnings

7MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.06
-0.85
-0.63
-0.42

Details

Expected EPS
-1.036712
Actual EPS
-0.95
Surprise EPS
0.09
Surprise Percent
+8.36%

Description

Entrada Therapeutics (TRDA) has reported earnings of -0.95 per share for Q2 2026.

0 Comments

Share your thoughts